Nightstar Therapeutics Plc's ROA from the first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nightstar Therapeutics Plc's ROA in the first quarter of 2019?
Nightstar Therapeutics Plc recorded a cumulative net loss of $-39 million during 12 months ending in the first quarter of 2019, resulting in a negative return on assets (ROA) of -33.03%.

However, within the Healthcare sector 370 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2019 quarter, so far to 4057, from total ROA ranking in the fourth quarter of 2018 at 4500.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter	(Mar 31 2018) I. Quarter
Y / Y Total Assets Change	27 %	40.21 %	-55.74 %	-61.61 %	692.95 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-39	-37	-42	-44	-41
Return On Assets (TTM)	-33.03 %	-33.9 %	-44.42 %	-38.99 %	-30.1 %
NITE's Total Ranking	# 4057	# 4500	#	#	#
Total Assets (TTM) in million	170	190	60	52	134
Seq. Total Assets Change	-10.46 %	216.79 %	15.28 %	-61.16 %	-1.15 %
Seq. Net Income Change	-	-	-	-	-

NITE's 5 Years Annual ROA >> Back to NITE Management Effectiveness >> Compare NITE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 34
Sector	# 371
Overall	# 3872

Return On Assets Statistics
High	Average	Low
-21.96 %	-25.1 %	-26.77 %
(Dec 31 2017)		(Dec 31 2018)

Financial Statements
Nightstar Therapeutics Plc's Assets	$ 170 million	NITE's Balance sheet
Nightstar Therapeutics Plc's Income	$ -16 million	Quarterly NITE's Income Statement
NITE's Income by Division		See NITE's Income by Division

Annual Return On Assets	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	FY	FY	FY
Y / Y Total Assets Change	35.28 %	-	-	-	-
Total Assets in million	190	140	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-37	-30	0	0	0
Annual Return On Assets	-19.44 %	-21.18 %	-	-	-

NITE's 5 Years Annual ROA >> Back to NITE Management Effectiveness >> Compare NITE ROA to its Competitors

More Return On Assets Ratios
NITE's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NITE's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NITE's Competitors
Subscribers only: Roa for Nightstar Therapeutics Plc's Suppliers
Subscribers only: Return On Assets for NITE's Customers

You may also want to know
NITE's Roi	NITE's Inventory Turnover Ratio	NITE's Growth Rates	NITE's Dividend Comparisons
	NITE's Profitability Ratios	NITE's Asset Turnover Ratio	NITE's Dividend Growth
NITE's Roe	NITE's Valuation Ratios	NITE's Financial Strength Ratios	NITE's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2019, within Healthcare Sector

ROA

Date modified: 2026-09-08T21:14:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.